Marijuana Company of America (OTC: MCOA) is a diversified holding company with operations and investments throughout the cannabis industry. MCOA changed its strategy in 2020 to focus on sales and marketing efforts of its wholly owned hempsmart™ premium brand of hemp-based CBD (legal cannabidiol) products both domestically and internationally.
Strategic decisions and long-range planning have also led the company to pivot away from farming and focus on supplying the cannabis industry across an ever-expanding market landscape.
The company recently announced it has completed the acquisition of cDistro, LLC (“cDistro”). cDistro is one of the hemp industry’s fastest growing distribution companies and is expected to deepen the Company’s distribution presence in North America.
Founded in the summer of 2020, cDistro offers the CBD brands along with smoke and vape shop related products to wholesalers, c-stores, specialty retailers, and dispensaries in North America. cDistro has seen rapid growth since its inception accumulating a catalog of eight product lines currently being sold to over 250 customers. cDistro currently generates approximately $150,000 per-month in gross revenues with generous margins, which will be included in MCOA’s consolidated financial statements.
MedX Holdings, Inc. (OTC: MEDH) is a brands and acquisition company focusing its business model on cannabis as a commodity. Headquartered in Austin, Texas, the Company keeps a close eye on the marketing, development, execution and performance of cannabis operations in Colorado and Oklahoma. Through this observation, MedX sees considerable opportunity to build on the foundation laid by other businesses to introduce an immersive experience for cannabis consumers.
Recent CEO interview with smallcapvoice.com: https://www.smallcapvoice.com/may-interview-medx-holdings-medh/
American Premium Water Corporation (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health, beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Cali Bear (www.calibear.life) Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.co).
The company recently announced it has come to terms on the acquisition of licenses to distribute and retail hemp cannabinoids in the State of New York as part of the State’s program to establish quality control standards on the industry.
The Company expects to close the transaction by the end of the 1st half 2021. (Disclosure: The Company acquired these licenses from a New York entity that was owned by CEO, Ryan Fishoff. The proposed consideration for the licenses is nominal.)
Goldman Small Cap Research, a sponsored research provider focused on microcap stocks, has issued a new research update. This update highlights the impact of the Company recent developments, including its joint venture with Cali Bear (www.calibear.life).
In the sponsored research update, analyst Rob Goldman affirms his price target of $0.0425 and his investment thesis, noting that the news reflects a milestone event that is wide-reaching for the Company in terms of revenue, cross-selling opportunities, and a reach into new markets.